Journal of Evaluation in Clinical Practice

Optimal two‐stage breast cancer screening for countries with intermediate or low incidence of breast cancer

Journal Article

  • Author(s): Shou‐Jen Kuo, Tony Hsiu‐Hsi Chen, Amy Ming‐Fang Yen, Dar‐Ren Chen, Li‐Sheng Chen
  • Article first published online: 24 Aug 2010
  • DOI: 10.1111/j.1365-2753.2009.01341.x
  • Read on Online Library
  • Subscribe to Journal

Abstract

Objectives  This study is to identify an optimal cut‐off for two‐stage breast cancer screening making allowance for variation of the baseline incidence rate and utility values between sensitivity and specificity.

Methods  We used data from a two‐stage breast cancer screening of Taiwanese women aged 50–69 years for whom risk stratification was based on a composite risk score (conventional risk factors); subjects with a risk score greater than the cut‐off score were screened using mammography. The Bayesian posterior risk for breast cancer was computed by incorporation of the baseline incidence rate and the risk score. Bayes' maximum utility decision rule was then developed to determine the optimal screening cut‐off.

Results  With a risk score of −9 applied to the current two‐stage breast cancer screening programme, we could detect one breast cancer case for every 1406 women. Given different predetermined risks, the selected cut‐offs were −9 for 1:1200, −8 for 1:800, −4 for 1:600, −1 for 1:400 and 3 for 1:200 for women aged 50–59 years. When the regret utility ratio of positive predictive value to negative predictive value was set at 1:10, the specificity and sensitivity were 58.5% and 70.4%, respectively, and the optimal cut‐off was −5.5. When the ratio was set at 10:1, the sensitivity and specificity were 75.5% and 57.1%, respectively, and the optimal cut‐off value was −7.5.

Conclusions  This study demonstrates that Bayes' maximum utility decision rule can be used to determine optimal cut‐off values for two‐stage breast cancer screening in countries or areas with lower or intermediate incidence of breast cancer.

Related Topics

Related Publications

Related Content

Site Footer

Address:

This website is provided by John Wiley & Sons Limited, The Atrium, Southern Gate, Chichester, West Sussex PO19 8SQ (Company No: 00641132, VAT No: 376766987)

Published features on StatisticsViews.com are checked for statistical accuracy by a panel from the European Network for Business and Industrial Statistics (ENBIS)   to whom Wiley and StatisticsViews.com express their gratitude. This panel are: Ron Kenett, David Steinberg, Shirley Coleman, Irena Ograjenšek, Fabrizio Ruggeri, Rainer Göb, Philippe Castagliola, Xavier Tort-Martorell, Bart De Ketelaere, Antonio Pievatolo, Martina Vandebroek, Lance Mitchell, Gilbert Saporta, Helmut Waldl and Stelios Psarakis.